DNAprint Genomics (DNAG)

[frogdreaming]

Virgil, Well we appear to be making progress.

Can't we have at least some confidence that the Super-EPO will probably benefit from DNAprint's personalized medicine technology?

We can suppose that IF DNAprint has a personalized medicine technology, (There is currently no evidence to suggest they have.) and IF the Super-EPO ever manages to get close to the end of the drug development pipeline (the vast majority of drugs do not complete the process) and IF there is any variability in the results across the patient spectrum, THEN the drug may benefit from DNAprint.

And what about the other theranostic and diagnostic products in the pipeline? Don't they have a real connection to personalized medicine?

IF they actually exist, then some of them will certainly connect to personalized medicine. Unfortunately while the pipeline seems to get longer and longer with new things being inserted all the time, nothing related to personalized medicine has ever come out of it. Even those products that have been imminent for five years now seem to be retreating from the outflow at a noticeable rate.

I am also interested in knowing how you are so sure the Super-EPO is just an "experimental compound." How do you know it is so far from the stage when we will know if it presents the same variable elements as EPO?

We will not know if it presents the same variable elements until it is tested on patients in a clinical study. Clinical studies are regulated by the FDA and are reported to the public. The process through the various stages takes years. It has not yet begun. We are a long way from obtaining variability data on which to construct a classifier.

regards,
frog